A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute Interventions: Drug: CC-90009; Drug: Venetoclax; Drug: Azacitidine; Drug: Gilteritinib Sponsors: Celgene; AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials